459 related articles for article (PubMed ID: 15190072)
1. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
2. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation.
Kyo S; Sada K; Qu X; Maeno K; Miah SM; Kawauchi-Kamata K; Yamamura H
Genes Cells; 2003 Oct; 8(10):825-36. PubMed ID: 14531861
[TBL] [Abstract][Full Text] [Related]
4. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
[TBL] [Abstract][Full Text] [Related]
5. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
Hunter S; Burton EA; Wu SC; Anderson SM
J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
[TBL] [Abstract][Full Text] [Related]
6. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.
Chernock RD; Cherla RP; Ganju RK
Blood; 2001 Feb; 97(3):608-15. PubMed ID: 11157475
[TBL] [Abstract][Full Text] [Related]
7. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
8. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.
Magnifico A; Ettenberg S; Yang C; Mariano J; Tiwari S; Fang S; Lipkowitz S; Weissman AM
J Biol Chem; 2003 Oct; 278(44):43169-77. PubMed ID: 12907674
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
van Leeuwen JE; Paik PK; Samelson LE
Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
[TBL] [Abstract][Full Text] [Related]
11. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
12. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
Hall AB; Jura N; DaSilva J; Jang YJ; Gong D; Bar-Sagi D
Curr Biol; 2003 Feb; 13(4):308-14. PubMed ID: 12593796
[TBL] [Abstract][Full Text] [Related]
13. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop.
Mason JM; Morrison DJ; Bassit B; Dimri M; Band H; Licht JD; Gross I
Mol Biol Cell; 2004 May; 15(5):2176-88. PubMed ID: 15004239
[TBL] [Abstract][Full Text] [Related]
15. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
[TBL] [Abstract][Full Text] [Related]
16. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase.
Anderson SM; Burton EA; Koch BL
J Biol Chem; 1997 Jan; 272(2):739-45. PubMed ID: 8995358
[TBL] [Abstract][Full Text] [Related]
19. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.
Rubin C; Litvak V; Medvedovsky H; Zwang Y; Lev S; Yarden Y
Curr Biol; 2003 Feb; 13(4):297-307. PubMed ID: 12593795
[TBL] [Abstract][Full Text] [Related]
20. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
